London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Wondered how long it would be before someone thought they should have a testing kt for 'Euphoria'. Currently I am struggling having tested positive for 'Boredom'
Last post: jamrock, 13 Jun 2024 14:53
One thing is 100% clear is that by working with Boots MHC has access to the public both with online presence on Boots website and also instore. Boots clearly in place in many stores facilities which allow the public to book appointments privately. If MHC can in some way agree a strategy and exclusive agreement with Boots that allows people to buy the tests and the bloods taken in store etc this will be significant both for private and future NHS testing. At present it’s the private sector I believe that this facility applies to however even Rishi Sunak stated last night in his talk on TV that pharmacist has a role to play in Reducing waiting lists etc. This will have to in some way include in store testing in my opinion. I truly believe the future is Boots testing service and MHC has worked that out. We all know Boots has been around a long time and no other high street brand more recognised and trusted like Boots for healthcare. MHC fully funded to stock products in another 200 stores as recently stated in the meeting.
I personally believe an announcement due in due course that could be game changing.
Penny is Professional and understands her field. Hard for many LTHs to understand the long term picture when the short term is painful.I could be wrong but definitely feels like both governments are aware of the need to tackle the GPs waiting list issue.
Amy
So based on your theory a capitalist market doesn’t work. I would say it definitely feels that your theory is plausible over the last 2-3 years since both Covid and the Ukrainian war that has had a dramatic impact on a lot of companies. If not as a direct result but the macro economics attached to the effects of the war. Inflation has killed many companies and rising interest rates both as a direct result of the above mentioned.
I’d say MHC has balanced the books extremely well given the events over the last year however the markets certainly haven’t been kind to MHC. All they can do is try and do do deals and continue with a plan to growth which it can turn in to profits.
Many companies have really burnt cash at an astonishing rate. The Aim definitely ain’t been kind to investors over the past few years and most certainly it could be argued you’d have been better and safer with your cash in the bank.
Hopefully MHC has it time but will it help most investors. I suspect most won’t recover original investment unless they average down.
Rarely pays to invest long term over multiple years. Most stocks are on AIM to have access to funds via dilution. There are some amazing cycles to exploit buying extreme oversold conditions or quiet conditions, then selling when europhia inevitably kicks in at somepoint. The cycles don't lie but often the long term trend is down for the majority
Jamrock, I am frightened to check my average for break even! Like you have been in here since Uncle Eric was in charge (wonder how the child birth figures pan out in China - probably lots of excited young mums!). Oh well. I only stand to lose 35k if the company folds or is taken over - don't miss it now as accumulated over more than a decade lol!
happy days everyone and good fortune
I what the average share price to breakeven is for most holders!
Last post: jamrock, 11 Jun 2024 12:32
Spindok
Love that one
This really made me chuckle :)
I've tucked a fw away today around 10p
Thanks for your replies. It does not take much to move this down or like today, up..
This goes up and down faster than a Singapore airliner!!
Started: spindok, 10 Jun 2024 14:23
Last post: spindok, 10 Jun 2024 14:23
I intend to wait until the end of the month to consider whether to hold ofr sell. Get the agm out of the way and perhaps have a trading update for the period since the beginning of the year. It will also be much clearer whois likely to congregate
in the house a babble...
Spin
Penny also alerted to other companies haemorrhaging cash at an alarming rate. I genuinely believe the company is well run and extremely prudent in cash burn etc. She wouldn’t answer questions regarding cash burn as no would really expect her to answer that question. She was clear they had a healthy balance sheet and well funded which is good news for shareholders. Additionally adding 200 stores stocking products will come at a cost to kit the stores etc. Penny alerted to opportunities in the B2B area also. I hope Penny and the board are in a position to offer news soon to change the direction of the share price. The market is brutal and there’s no way a company with funds to self fund should be on a market cap of around 5m. Many companies with much higher market caps in dire positions compared to MHC but hopefully news can change this. I do feel that MHC should have gone out to win the contract ABDX won but I guess Boots were also thinking about ABDXs other test(pregnancy one) when they awarded it. Is the space going to be full of acquisitions because I don’t believe there’s enough money for all of them to be viable. I believe this is why MHC has a different strategy with digital data and phlebotomy tests in the future to ramp up revenue. Also open opportunities in B2B area. I do believe MHC should also look to Gyms etc for deals as most conscious people looking to take control of personal health try a gym at some point.
I hope for all LTHs MHC is able to get news flowing before the next results because the markets can destroy a company as easy as it can make it.
Good look all
Thanks for your summary. I value your opinion. I bought a few on Monday before the results which I intend to hold.. I think the next few months will bring about some good news... GL
Spin
Penny was clear that LFT weren’t her priority However Covid revenue had been and continued to important.
LFT tests were small margins and she stated phlebotomy tests were her focus.
It’s understandable why she wants to expand stores for tests I suspect news on a deal with Boots allowing Rhe phlebotomy tests to be carried out in Boots. This is why they are focused on the digital data etc I guess. They clearly have an idea and if the deal gets over line it would be a game changer in my opinion.
In the short term who knows where the share price goes but this is why I feel the boards hands are tied to buy shares personally.
Just my view
Did you watch the web broadcast. I missed it due to a traffic jam. Looking at the sp today assume it did not reveal a lot...
Definitely no point in existing holders bailing unless you’re happy to materialise loses. It’s definitely going to be interesting to listen to the board meeting.
It will interesting to see if any asks about the board’s intentions to buy at these levels!.
I personally feel the best opportunity for MHC would be if the Pharmacy first was extended to include More tests that include MHC products but that is more of a wishful thinking at this point.
I do feel Covid revenue will be ongoing at lower levels but MHC need to show growth in new tests to convince the market. Its current valuations warranted based on competition companies who have survived by dilution etc such as ABDX.
These results were no surprise however they have cash to survive so I’m interested in a plan. The survival and expansion will need growth in new tests 100%. The time has come for the board to show leadership and a meaningful investor’s meeting is required. I’m not disappointed by the lack of a dividend however would have thought a buyback inevitable given the share price!. Maybe given they have left it so long to issue results up to 31st December they may have something else to announce when first half figures announced. They have prepared us for a Covid slowdown however all eyes on new products.
Most investors over 80-90% down you have to sit tight in my opinion.
The positive is they shouldn’t need any cash raises however the revenue growth must be shown.
Agree, total sales of new tests of about £344k for the year on a turnover of £11m is a tiny amount and exposes a serious risk to viability if the covid revenues drop off any more. It felt like a missed opportunity to set out more about the way ahead, beyond that it can be funded from existing cash balances, whatever it is. Without something more solid on the fact there is cash in the bank feels like there is no plan and suspect the SP reflects that sentiment if seen the same way by others.
It feels like MHC is in a bit of a holding pattern with either a dive because covid income drys up and cash burn will eat the reserves within 18-24 months based on current income / profit from new tests or more of the same with no news as there is nothing to update shareholders or the market on as there is no plan. The only other alternative I can think of is trying to make MHC appeal to a buyout or takeover. With a market cap below cash in the bank the SP seems low but with the lack of vision being shown I can understand why it is where it is.
Holding for now as sitting on too big a loss to make it worth bailing out!
45% increase of not a lot is erm,... Not a lot!!
Smudge
It appears the new tests are gaining traction however it appears a bit vague on things. We all it will take time but I personally feel we can not depend too n Boots alone. Whilst it’s a great strategy and valuable moving forward we must realise Boots have no loyalty demonstrated by the recent contracts with ABDX.
The cash could be used to expand into other main stream retailers,Gyms for weight management tests and vitamin tests etc. Also expand into Tik Tok shop etc. Maybe they will offer something later.
These results are what most anticipated and it’s positive to see new tests appear to be gaining traction however it’s a challenge to get them noticed as a change from normal habits of calling a GP.
Still we must commend them for be self sufficient.
Anyway I’m probably biased towards MHC as do believe they are onto something if they utilise the digital data etc. The problem is how must the digital data costs compared to income derived from it.
Stay positive
Revenue halving from 22 million to 11 million is the biggest issue here. That is a substantial worry IMO.
Cash is strong which is a positive, but how long is that going to hold up on those levels of revenue decline.
They have been playing the 'self-funded for next phase of growth ' card for too long. They need someone capable of leading that transition, they can't just have their eggs in one basket (Boots).
Started: spindok, 4 Jun 2024 08:14
Last post: spindok, 4 Jun 2024 08:14
Covid made this company. It experienced a boom and now has to re invent itself to avoid a bust. Not easy to do but it has the ammuntion to rebuild itself and appears to be heading in the right direction. It remains to be seen if investors think it has got it right..
Started: LondonMarket, 4 Jun 2024 07:29
Last post: HunSen, 4 Jun 2024 07:33
You missed this which is quite positive in my view:
Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, said: "2023 was a pivotal year for MyHealthChecked as the Company's focus moved to our Wellness test portfolio. We launched 23 tests, of which 21 are now available in Boots stores and online and we have seen over 45% increase in unit sales since Q4 2023. All of this would not have been possible without the revenue generated from COVID testing in prior years which has allowed us to implement a clear strategy, creating future growth opportunities and longevity for MyHealthChecked.
"The Company is now in a strong position with sufficient working capital available to fund the next growth phase as we continue to prioritise quality and customer service to become a leading supplier in the wellness testing sector. I would like to thank the MyHealthChecked team for their continued hard work over the last year and our shareholders for their ongoing support."
An increase of 45% sales is excellent, the products have generally good reviews on the Boots website. I believe the update should be seen as a positive.
Revenue down, almost half. But cash up, or basically stable. Not sure how market will react
Financial highlights
Revenue of £11.0m (2022: £22.3m)
Adjusted EBITDA of £0.015m (2022: £2.26m)
Cash balance at year end of £7.75m (2022: £7.61m)
Strong cash position to ensure next growth phase remains self-funded
Commercial and operational highlights
Retail launch of 21 tests in Boots, the UK’s largest pharmacy retailer
Ongoing strong relationship with Boots
Sustained unit sales growth of Wellness portfolio since launch
Achievement of Healthcare Inspectorate Wales Certification
Migration to Digital Quality Management System (“QMS”)
Self-funded ongoing digital enhancements and investment in compliance and governance
Started: SeedyG, 22 May 2024 21:11
Last post: jamrock, 2 Jun 2024 13:19
Https://news.sky.com/video/general-election-tories-would-free-up-20-million-gp-appointments-by-the-end-of-the-next-parliament-says-health-secretary-13146752
Can MHC eventually benefit and help the Government reduce GP appointments by encouraging them to allow pharmacy’s first to take up some simple tests that can be performed over the counter on the NHS. Will they expand the already 7 tests allowed to be increased to include MHCs tests. Is this why Boots are starting to have their own brand in Iron tests and vitamin D tests etc. Will Penny offer any information regarding plans. The time has arrived for a detailed strategy outside of Covid Revenue.
Will long term holders get some good news or will it be an opportunity missed
Hopefully some positives in the results however I hope we see through Covid revenue slowing and concentrate on new product sales
Https://finance.yahoo.com/news/theres-no-shortage-growth-recently-083330384.html
Seriously no one expects a multi bagger but can Penny get it back on track to better times moving forward.
Surely given its share price decline despite its cash position it due a re rate.
If Markets don’t get behind companies like MHC who have been prudent with cash through tough times you have to question the whole existence of stock investing.
Many companies end up private as a lack of value and support makes it impossible to grow if share prices are subdued because it’s impossible to use paper stock to leverage in order to finance deals to make acquisitions.
Imagine how many smaller companies MHC would have swallowed up if it was awarded its true valuation based on market average.
Is a market cap of less than 6m justified for a company with cash probably in excess of 8-9m despite reinvestment (ROCE).
Many will say I’m biased but if we look at the books of MHC compared to competitors it’s not difficult to see MHC have embarked on cash building rather than revenue growth. Can they now embark on a plan to grow revenue!.
Penny is at a critical point and must win the markets over with a convincing plan to grow revenue outside of Covid revenue.
Https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=MHC.L
It’s at a critical point after recent rise. 200 EMA needs to be broken to truly confirm we are out of a negative trend at 12.5p. Still happy to see it rise over the last few days on relatively average buying.
Any pent up buying pressure and we could break out!
MrM
I take on board your views however given how terrible many similar companies have performed and had to dilute many times to survive I personally feel Penny and the board should be commended.
Many may say I’m biased but MHC have been the one company able to make money from Covid sales after the endemic. Revenue that has enabled it to remain with a strong balance sheet and self sufficient.
I think all of us including me would welcome a growth plan strategy to enhance future revenue. One thing is we have opportunities to expand and remain in a strong position compared to peers however the markets haven’t rewarded MHC accordingly in my opinion.
Many said MHC would run out of cash two years ago however it has proven it has a prudent board able to manage cash burn to the extent it is on the verge of breakeven. Yes it has challenges ahead but if the wellness and wellbeing market has the support of an incoming government who truly wish to help shorten waiting times to see a GP then MHC is well placed to enable its tests to be used in a smart cost effective way.
I personally feel MHC should share a similar valuation to ABDX who truly have a cash burn issue however almost 2.5x the Market Capitalisation.
Penny should relish the 4th to demonstrate the future of MHC and maybe reward shareholders with good news and a potential dividend. I expect positive news on many new products however it’s still in early stages of traction.
The 4th will be interesting.
https://www.britishbulls.com/Default.aspx?lang=en
Last post: LondonMarket, 22 May 2024 20:14
MHC in the top risers?! What year is this, 2020!?
How long before selling price is raised to encourage sellers. Spread is a joke
This test is quite interesting, Thryoid issues can indicate some pretty serious diagnoses. So it makes sense why this test would sell well.
Hopefully there is something of interest with the upcoming reuslts. It has been far too long now.
Article in Cambridge News with comment from MHC ahead of World Thyroid Day on Saturday
Https://www.boots.com/myhealthchecked-thyroid-stimulating-hormone-%28tsh%29-rapid-test-10322822p
53 sold in 24hrs!
Is MHC in trials with NHS or something!
Never seen this many sold in 24rs before. Need MHC to do a deal with NHS allowing patients to buy direct tests without GP appointments needed.
Maybe I’m a little optimistic but seems a perfect way to gain traction.
The government recently announced 7 products not ours to be sold direct to patients to help with Overload on GPs.
Come on Penny surely the time is near for some announcements
Started: Tefteresia, 22 May 2024 09:28
Last post: Davand, 22 May 2024 14:14
Giz, I believe they are engineering this bird virus to take many more out this time. Upto 50% fatality some reckon. These elites need stopping . Hope this corrupt govt don't sign up to the WHO pandemic treaty on Friday. Gives them control over lockdown, vaccine mandates etc.
Hi davand ..if shareholders want growth ...it fits
My question to the board is how much old rope did Adam Reynolds and Lyn Rees make last year and how much will they be paid for it?
Does the company have anything for bird flu, as it's coming to your neighbourhood soon it appears. As Gates said, it'll get people's attention this time. Already released in the US and NZ. Wonder when it will escape one of our labs. Gain of function man made it seems, funded by the US . What a surprise.
My Question to the board is why so few deals with other retailers and Tik Tok shop etc. Also is it possible to work with the NHS to allow changes so patients can eventually buy tests and self test to save GP appointments. Hence saving for NHS = Profit for MHC.
Finally why no Directors buying!
Lots of questions I guess
Last post: spindok, 22 May 2024 10:13
At last a rns but with hardly anything to base a appaisal to buy would be a pure gamble...
Started: joshing_man, 10 May 2024 18:44
Last post: roly12, 13 May 2024 13:32
Given that he bought in at 19.25p I would say he is not happy.
I am still sitting on the sidelines here, not waiting for lower entry, but market update as to how all the new tests are doing.
Excuse my ignorance but who is he and why has it taken him 11 months to notify of this significant holding? Any great significance?
Started: joshing_man, 8 May 2024 14:13
Last post: jamrock, 9 May 2024 13:02
It’s in the boards hands 100%
Surely results soon.
Up to end of June I believe to issue results.
As pointed out cash position strong.
Guidance on new products needed.
Surely we get a positive plan but the whole Aim feels like a lottery atm.
The continued silence and absence of any update or figures is of grave concern. WallbrookPR has forgotten what PR stands for and Penny has confirmed exactly what she thinks of shareholders.
Hopefully when the next news is released we will hear enough positivity (and reality) in the talk and numbers to see the SP start to recover. It appears to be very undervalued based on the cash pile but the lack of progress is galling.
Yet another WEF, WHO attempt at depopulation I see. The 2030 agenda in full swing. I can never remember a time when the word pandemic has been so centre stage. All engineered man made apparently. Never heard the word in the 60s or following decades, now all of a sudden Gates can predict them .Hmmmm!
Https://www.dailystar.co.uk/news/world-news/new-covid-strain-dubbed-flirt-32747928?utm_source=linkCopy&utm_medium=social&utm_campaign=sharebar
Whilst it ain’t gone away it will continue to offer a revenue stream. All be it it looks like Covid sales whilst important and the future of MHC.
More advertising and awareness campaigns and we see an upside in the company sales and shares price.
Hopefully results soon. Hoping the market understands that Covid sales will have slowed from February.
Also hoping some of the new tests selling better in the shops to compensate Covid sales slow down.
Pennys statement will be important.
London Market
A 12,000 influencer doing a free one is better none as stated in the last update. At least it enables it to be shared however all exposure is great. Imagine if they had a plan to target more influencers and marketing strategies.
The fact is the board has done very little in advertising or next to nothing despite having 8m in the bank and promises of an advertising plan.
Good on the influencer who noticed the product.
More marketing welcome.
I wouldn't really call a 12k follower TikTok account an "influencer" but its good to see some exposure no matter how small
Https://vm.tiktok.com/ZGexCvXt2/
A Tik Tok influencer like the product.
Is this advertising the way!.
All forms of advertising is good exposure.
I have said Tik Tok is a great place to get your product noticed. Maybe we should be on the the Tik Tok shop.
Good on the influencer and I’d love to see them collaborate to get the other products noticed. After all Penny did state collaborations with influencers would happen.
Anyway how long before an update!
Started: spindok, 30 Apr 2024 13:14
Last post: jamrock, 30 Apr 2024 14:41
Some times you have to do what’s best and also your family and health. All shares are not the place if you have pressure etc. Any company can fly or go bust. Seen it a 100 times. Luck a lot of the time. Best not to do do day trading in my opinion but equally if your lucky enough take profit in any share
For me I have reached the end of the line with AIM shares. Over the last few months I have dumped all but two and those are on borrowed time. I want to rid myself from the day to day this Summer and so I have goe over to Footse 250 and
will just take the dividends in re invest. I know some investments are dividend traps but I have tried to choose very carefully those I have tucked away... MHC may go boom but I have been in since Concepta and made diddly squat.
Day trading has no appeal under the current climate... I will let you know in six months if I have made a wise decision.
Started: SeedyG, 19 Apr 2024 09:14
Last post: jamrock, 30 Apr 2024 08:12
Will MHC do something to enhance the share price!
What can they do!
Such a shame that the lack of deals and news flow has bought the price to near all time lows.
Can it do anything to change the current share price direction!.
In my opinion they need to announce contracts with a view to not relying on just Boots who clearly have their own plans to have their own brands etc.
Great product, great financial position but lack of visibility is hampering things.
Maybe Penny will offer us something with results but until then it feels a painful for long term holders
They have until June unfortunately but all we can do is wait and hope they have something positive but as it stands without news don’t expect a lot.
Most waiting for results but wouldn’t be surprised if they’re busy negotiating some new deals to break news before results.
They need some deals in my opinion. Looked on social media and couldn’t see much activity as mentioned in last years update!.
I've sent an e-mail to WallbrookPR asking when we can expect to see the results and any communication from Penny and a sign that the SP might rise.
Let's see if an answer is forthcoming and more importantly the results are out soon so I can decide whether to hold, buy or sell.
It’s definitely not been kind to shareholders who like me have taken huge risks however let’s wait for results and update. The news flow hasn’t been very good as you stated however sometimes there’s reasons for this so I’m waiting for finals before passing judgement.
I can however say I do understand the frustration however tucked my shares away until news.
Been a dog of a share to own so far and the lack of leadership, communication and interaction with shareholders is damning. The new products do not appear to be gaining any real commercial traction but maybe they will show that all is about to change. The SP is lower than it ought to be but frankly there is nothing from the company that warrants anything else.
Think it is just when they get around to it...
Last post: Robthebob, 17 Apr 2024 19:34
Maybe Erik Henau is returning with a buy out. Like you jamrock I am a long term holder (hit the million mark before restructuring) and have lost all excitement or enthusiasm for the B. of D. I suppose a buy out may not happen but the cash reserves alone would virtually pay for the buy out!
Wish Mystic Meg was around for some guidance.
Fair bit of buying though today as the unknown are clearly buys as selling price not near the price crossed so maybe a glimmer of hope results are due.
Learnt not to lose sleep waiting
Hope is hope.
In truth as much as I’m a LTH and own a lot of these the news flow is quite shocking
Right?? Hopefully some news coming in soon
Strange buying pattern here... Beginning to wonder if somebody knows something.
Last post: spindok, 15 Apr 2024 10:06
Lied... It was 19th!! zzz
The last update was January 18th so surely they will confirm this week than Penny has not turned into a Far Thing and all is going swimmingly. Only this morning I saw two pigs fly by.. I goimg back into hibernation as it is blowing a gale and pouring with rain. I am all honed and toned from two days of sun and dizzy temperature in the 20's.
Last post: jamrock, 15 Apr 2024 08:32
How can this share move higher with a 15% spread!.
Will the selling price rise or buying price to balance it up!
Will the company address concerns to get it moving. With cash in the bank are they missing an opportunity to expand!
Spin
It definitely feels like the Titanic or a company that have shut up shop. No results is causing investors to bailout.
No one knows what’s happening with the company and it’s clearly sending a negative feeling throughout the share price.
Just hope Penny has something to offer because communication skills wouldn’t receive 5 star at all.
Anyway all we can do is wait now. Never seen a stock with 8m in the bank and 5m market cap.
Even shell companies do better
Begining to resemble the Titanic. Everyday it sinks a bit more....Please please. Update.
Spin
I think the board has took big bonuses and early retirement.
Penny is busy preparing for the new Christmas Party
Last update was on 19.1.24. Just a gentle deep breathing coming from the bored room ....Big question is are they just snoozing or dead!!
Crazy low valuation
Spin
Many big sells today.
No rest for this one
There are a few buys today and it maybe because some form of update or results are due. I remain cautiously optimistic. Then I am bonkers!!
Started: Ambers235, 28 Mar 2024 09:24
Last post: jamrock, 1 Apr 2024 19:54
Albington health (ABDX) manufacture Boots tests.
Strange thing is sure we sold the facility to them.
I still think we should have put a cheeky bid in for them when the were struggling but the share price is slowly recovering as they continue to release good news. Still think ABDX are in need of a cash raise because the cash burn situation.
Do we know who manufactures or supplies the Boots tests? Could they just be white label versions of the MHC product?
Amber
Iron and vitamin tests available all over Amazon etc.
I do however agree they are aware of the tests that have most potential based on information.
MHC just need to have a plan of their own
So I see Boots now have their own brand tests - Vitamin D rapid Test £7.99 - same price point as our Vitamin D Test.
Positive step?
Have to assume Boots have done their DD and customer research here and see the potential ...
The flip is we now have a competing product